The event took place aboard a collaborative cruise in Puerto Rico between February and March, 2022. The group responsible for the core collection was led by Prof. Steven D’Hondt and Dr. Robert Pockalny from the University of Rhode Island’s Graduate School of Oceanography and included researchers and technicians from WHOI, University of Rhode Island, University of California San Diego, Oregon State University, University of Washington, University of Puerto Rico Mayagüez, and University of Munich.

Long sediment cores are generally collected by allowing a core pipe with a lead weight on top to fall through the water and into soft sediment that collects on the seafloor over long periods of time. When the pipe is pulled out of the seafloor and back up to the ship, the recovered sediment inside can be used to study Earth’s environmental conditions and climate dating back tens or hundreds of thousands, or even millions, of years ago.

Scientists are also interested in understanding genetic traits that enable microscopic organisms to survive within seafloor sediments. The main objective of this expedition was to better understand how microbes at different depths below the seafloor have adapted to vastly different environmental conditions present across the entire depth range of the trench. Over the course of three weeks at sea, the team collected cores from a water depth of about 50 meters (165 feet) to the trench’s maximum depth of about 8,385 meters (27,510 feet).

“We took these cores to learn how microbes that live beneath the seafloor respond to pressure,” said D’Hondt. “Our ultimate objective is to improve understanding of how organisms in extreme environments engage in the world around them. “Our team’s success in extracting this core from the deepest part of the Atlantic Ocean will enable us to make a tremendous advance in our understanding of this little-known part of life on Earth.”

The core collections were made possible by the long core system originally developed at WHOI in 2007 by then-research specialist Jim Broda for the research vessel Knorr. After the ship’s retirement, the system was adapted to fit the slightly shorter vessel Neil Armstrong. After this expedition, the long corer will be transferred to the OSU Marine Sediment Sampling Group, which is funded by the U.S. National Science Foundation and supports coring operations throughout the U.S. academic research fleet, so it can be made available to the entire oceanographic community.

“This achievement was only possible thanks to phenomenal teamwork by everyone involved, including those who helped develop the long corer nearly 20 years ago,” said Rick Murray, WHOI Deputy Director and Vice President of Science and Engineering. “The fact that the long corer will move to the capable hands of our friends and colleagues at Oregon State University means it will have many more years of use by the ocean science community to help advance knowledge about our planet.”

Story Source:

Materials provided by Woods Hole Oceanographic Institution. Note: Content may be edited for style and length.

All ship channels must be regularly cleared of sand, debris settled on the bottom (called shoal) and miscellaneous trash. That means ship channel management regularly faces the mighty task of dredging. How do they make the wisest decisions with the best timing?

“The quandary involves weighing factors for the optimal decision of channel dredging and disposal activities,” said Zheyong Bian, assistant professor of construction management at the University of Houston College of Technology and the lead author of a study published in the journal Transportation Research Part E: Logistics and Transportation Review. “Some factors are static, like geographical features of navigation channels and confined disposal facilities. Others vary substantially, such as navigability condition deterioration (shoaling), traffic, economic values, annual budget and more.”

Bian, then a doctoral student at Rutgers University, The State University of New Jersey, collaborated with project leader Yun Bai from the Center for Advanced Infrastructure and Transportation (CAIT) at Rutgers, to develop a dredging planning optimization model (DPOM) and a dynamic prioritization planning (DPP) algorithm that factor in known variables, such as the volume of debris expected and availability of nearby confined disposal facilities. It also considers grouping phases of the project and how costs can be affected by interest rates and inflation.

But — this is a key advantage, Bian stressed — the algorithm also holds the flexibility that weighs input from local professionals. In other words, it values boots-on-the-ground opinions and learns from experience.

Once all factors are included, the algorithm suggests timing, prioritization and the grouping of projects. It also projects costs, with interest and inflation included, as well as monies likely to be recouped (through repurposing of sand, for example).

In these days of tightened budgets, public funds are deployed with ever more care. The new DPOM model and DPP algorithm could strengthen cost efficiencies at ship channels around the world. The New Jersey Department of Transportation Office of Maritime Resources provided funding and data to support this study.

Story Source:

Materials provided by University of Houston. Original written by Sally Strong. Note: Content may be edited for style and length.

Neuroscientists believed that, in the aftermath of a stroke, calming overexcited neurons might prevent them from releasing a toxic molecule that can kill neurons already damaged by lack of oxygen. This idea was supported by studies in cells and animals, but it lost favor in the early 2000s after numerous clinical trials failed to improve outcomes for stroke patients.

But a fresh approach has yielded evidence that the idea may have been discarded too hastily. The new findings are available online in the journal Brain.

By scanning the whole genomes of nearly 6,000 people who had experienced strokes, researchers at Washington University School of Medicine in St. Louis identified two genes associated with recovery within the pivotal first 24 hours after stroke. Events — good or bad — that occur in the first day set stroke patients on their courses toward long-term recovery. Both genes turned out to be involved in regulating neuronal excitability, providing evidence that overstimulated neurons influence stroke outcomes.

“There’s been this lingering question about whether excitotoxicity really matters for stroke recovery in people,” said co-senior author Jin-Moo Lee, MD, PhD, the Andrew B. and Gretchen P. Jones Professor and head of the Department of Neurology. “We can cure stroke in a mouse using blockers of excitotoxicity. But in humans we performed numerous clinical trials, and we couldn’t move the needle. Every last one of them was negative. In this study, out of 20,000 genes, the top two genetic hits point to mechanisms involving neuronal excitation. That’s pretty remarkable. This is the first genetic evidence that shows excitotoxicity matters in people and not just in mice.”

Every year nearly 800,000 people in the U.S. have ischemic strokes, the most common kind of stroke. Ischemic strokes occur when a clot blocks a blood vessel and cuts off oxygen to part of the brain, triggering sudden numbness, weakness, confusion, difficulty speaking or other symptoms. Over the next 24 hours, some people’s symptoms continue to worsen while others’ stabilize or improve.

In the 1990s, Dennis Choi, MD, PhD, then head of the Department of Neurology at Washington University, performed groundbreaking research on excitotoxicity in stroke. He and others showed that stroke can cause neurons to release large amounts of glutamate, a molecule that transmits excitatory messages between neurons. Glutamate is constantly being released by neurons as part of the normal functioning of the nervous system, but too much all at once can be toxic. Efforts to translate this basic research into therapies for people did not pan out, and eventually pharmaceutical companies let their anti-excitotoxic drug development programs lapse.

But Lee, who formerly worked on excitotoxicity with Choi, did not give up. He teamed up with genetics researcher and co-senior author Carlos Cruchaga, PhD, the Barbara Burton and Reuben M. Morriss III Professor of Neurology and a professor of psychiatry; first author Laura Ibañez, PhD, an assistant professor of psychiatry; and co-author Laura Heitsch, MD, an assistant professor of emergency medicine and of neurology, to tackle the question of what drives post-stroke brain injury. The team identified people who had experienced strokes, and they looked for genetic differences between those who naturally recovered substantial function in the first day and those who did not.

As members of the International Stroke Genetics Consortium, the research team was able to study 5,876 ischemic stroke patients from seven countries: Spain, Finland, Poland, the United States, Costa Rica, Mexico and South Korea. They measured each person’s recovery or deterioration over the first day using the difference between their scores on the National Institutes of Health (NIH) Stroke Scale at six and 24 hours after symptoms first appeared. The scale gauges a person’s degree of neurological impairment based on measures such as the ability to answer basic questions such as “How old are you?”; to perform movements such as holding up the arm or leg; and to feel sensation when touched.

The researchers performed a genomewide association study by scanning the participants’ DNA for genetic variations related to the change in their NIH stroke scale scores. The top two hits were genes that coded for the proteins ADAM23 and GluR1. Both are related to sending excitatory messages between neurons. ADAM23 forms bridges between two neurons so that signaling molecules such as glutamate can be passed from one to the other. GluR1 is a receptor for glutamate.

“We started with no hypotheses about the mechanism of neuronal injury,” Cruchaga said. “We started with the assumption that some genetic variants are associated with stroke recovery, but which ones they are, we did not guess. We tested every single gene and genetic region. So the fact that an unbiased analysis yielded two genes involved in excitotoxicity tells us that it must be important.”

In the years since anti-excitotoxic drug development was abandoned, clot-busting drugs have become the standard of care for ischemic stroke. Such drugs aim to restore blood flow so that oxygen — and anything else in the bloodstream, including medication — can reach affected brain tissue. Consequently, experimental neuroprotective therapies that failed in the past might be more effective now that they have a better chance of reaching the affected area.

“We know that that first 24-hour period has the greatest impact on outcomes,” Lee said. “Beyond 24 hours, there’s diminishing returns in terms of influence on long-term recovery. Right now, we don’t have any neuroprotective agents for that first 24 hours. Many of the original studies with anti-excitotoxic agents were performed at a time when we weren’t sure about the best trial design. We’ve learned a lot about stroke in the last few decades. I think it’s time for a re-examination.”